We Serve

Investors

Diagnostics companies are building the infrastructure precision medicine runs on. The product to launch, the channel to lead with, the indication to anchor a development pipeline, the category to enter next, the growth strategy when the core market matures — these are the decisions that determine where a Dx company wins, how it reaches its market, and which categories are worth building for.

What we do

Select Capabilities

All Capabilities

Patient / Diagnostic Journey Mapping

As the precision medicine technologies and treatments evolve, so does the patient journey. Understanding how your products and services fit into the patient journey, and the barriers or challenges you may face, is critical to realizing your market potential.

View

Biomarker and Diagnostics Strategy

This is where precision medicine starts – whether you’re trying to find the right tools to uncover new biomarkers, identify CDx partners, launch an IVD, or understand how your assay will fit into the clinical journey, DeciBio has you covered. Nobody knows biomarkers and CDx better than DeciBio.

View

Go-to-Market Strategy

It’s time to execute. Understanding your customers, competitors, channels, and messaging is just the first step. Going to market requires coordination and alignment across the organization, and an ivory-tower strategy won’t be enough - you need tactics.

View